Nitrous oxide (N 2 O) has been clinically used for 170 yr and exerts an antinociceptive action without major side-effects. At the molecular level, N 2 O inhibits the N-methyl-D-aspartate (NMDA)-type of ionotropic glutamate receptors, 1 but controversies still remain with respect to the mechanisms of its pharmacological actions. 2 Naloxone, an opioid receptor antagonist, reverses the antinociceptive effect of N 2 O, which suggests that opioid peptide release and opioid receptor activation are involved in this action of N 2 O. 3 However, it is unclear which of the naloxone-sensitive opioid receptors, including the m-, k-, and d-opioid receptors (MOP, KOP, and DOP, respectively), 4 is the most important in the pharmacological action of N 2 O. Our previous report demonstrated that the antinociceptive effect of N 2 O is not influenced by genetic deletion of MOP 5 and is significantly reduced by a KOP-selective antagonist, but unaffected by a DOP-selective antagonist, 6 suggesting that KOP is important in the antinociceptive action of N 2 O. The mechanism for the hypnotic action of N 2 O is also unknown. Based on gene knockout (KO) experiments, it was shown that the NMDA-type of the glutamate receptor does not participate in the hypnotic action of inhaled anaesthetics, including isoflurane, sevoflurane, and N 2 O. 7 However, it has not been investigated whether the opioid receptor mediates the hypnotic action of N 2 O by the use of the KO mice. The minimum alveolar concentration (MAC), EC 50 value of inhaled anaesthetics for immobilizing effect to noxious stimulus, has been frequently used to compare anaesthetic potency of different inhaled anaesthetics. It remains unclear whether the opioid receptor is involved in the pharmacological action of volatile anaesthetics which determines MAC. Dahan and colleagues 8 showed that naloxone induces elevation of the sevoflurane MAC in mice, and the sevoflurane MAC in MOP-KO mice is 20% higher than that in wild-type (WT) mice. Contrarily, Liao and colleagues 9 reported that the sevoflurane MAC was not significantly affected by naloxone. We have shown that MACof sevoflurane, isoflurane, and halothane is not significantly affected by MOP deletion, which suggests that the pharmacological action of volatile anaesthetics which determines MAC is not mediated by MOP. 5 However, involvement of opioid receptors other than MOP in this action has not been examined using KO mice. Thus, using KOP-KO mice, we aimed to clarify whether KOP mediates the antinociceptive and hypnotic effects of N 2 O and whether MAC of N 2 O and volatile anaesthetics is affected by KOP activation.
Methods

Animals
WT C57BL/6 mice and KOP-KO mice [strain: B6.129S2-Oprk1 (tm1Kff)/J, stock number: 007558] aged 6 -10 weeks were obtained from Japan SLC Inc. (Shizuoka, Japan) and Jackson Laboratory (Bar Harbor, ME, USA), respectively. The total number of mice used in this study was 121 for WT and KOP-KO mice, respectively. Animals were housed in a temperaturecontrolled environment (22 -268C, 50% relative humidity) with lights on from 7 a.m. to 9 p.m. during an acclimatization period of at least 1 week and could freely access food and water. After this period, all tests were performed between 9 a.m. and 3 p.m. All experiments were approved by the Animal Research Committee of Kyoto University, and were performed according to Guidelines for Proper Conduct of Animal Experiments established by the Science Council of Japan, and relevant aspects of the ARRIVE guidelines. In each experiment, treatment order of WTand KO mice was randomized, and mice were randomly allocated to the treatment groups in each genotype. Every effort was made to minimize animal suffering and reduce the number of animals used. In the c-Fos immunohistochemical study, the mice were killed by high dose of sodium pentobarbital as described below. In the other experiments, the mice were humanely killed by CO 2 inhalation followed by cervical dislocation after measurements. After acetic acid writhing test, the mice in a great deal of pain were immediately euthanized. The investigator who performed the measurements (H.F.) was blinded to both the mouse type and the treatment.
Drugs and chemicals
The drugs and chemicals used in the experiments were U-50488 (Sigma Chemical, St Louis, MO, USA), an agonist selective for KOP; 10 acetic acid (Nacalai Tesque, Kyoto, Japan); N 2 O (Wakayama Sanso, Wakayama, Japan); oxygen (O 2 ) and nitrogen (N 2 ) (Taiyo Nippon Sanso Co., Tokyo, Japan); and sevoflurane and isoflurane (Abbott Japan Co., Tokyo, Japan).
Measurement of MAC
The MAC values of sevoflurane and isoflurane were estimated as described previously. 8 9 11 12 Briefly, mice were individually placed in a transparent plastic cylinder (15 cm in length, 5 cm in diameter), and allowed to breathe spontaneously while inhaling sevoflurane or isoflurane at a total gas flow of 2 litre min 21 (100% O 2 ). To keep the rectal temperature between 36.5 and 37.58C, mice were warmed with a heat lamp and a warm blanket (Animal Blanket Controller ATB-1100, Nihon Kohden, Tokyo, Japan). The concentration of sevoflurane or isoflurane was monitored by an infrared gas analyser (Capnomac Ultima, Datex-Ohmeda, Helsinki, Finland). An anaesthetic vaporizer (Aika, Ichikawa Shiseido, Tokyo, Japan) was used to vaporize the volatile anaesthetic. Mice inhaled each anaesthetic gas for 20 min and then a 1 min noxious stimulus was applied to the tail with an alligator clip. The stimulation site on the tail was always selected proximal to the previous test site. A gross movement of the head, trunk, or extremities was judged as a positive response. The concentrations of sevoflurane and isoflurane were raised in increments of 0.3% and 0.1%, respectively, and the MAC was calculated as the mean of the highest concentration allowing a positive response and the lowest concentration preventing this response. The sevoflurane and isoflurane MAC was determined for WT and KOP-KO mice (n¼6, respectively).
The influence of N 2 O on sevoflurane MAC was analysed in WT and KOP-KO mice (n¼18, respectively). The mice were allocated to the control, N 2 O, and KOP agonist groups (n¼6, respectively). At the beginning of the equilibration period, mice of the KOP agonist group received 10 mg kg 21 The antinociceptive effect against visceral pain in WT and KOP-KO mice was evaluated using an acetic acid writhing test (n¼24, respectively). 13 Each mouse was placed in a transparent plastic chamber (12 cm in height, 22 cm in diameter) and allowed a 1 h acclimation period. Mice were pretreated as described above, inhaled the gas mixture for 30 min at a total gas flow rate of 5 litre min 21 , and were then injected with 0.7% acetic acid (0.1 ml 10 g 21 of body weight) intraperitoneally (i.p.). Five minutes after acetic acid injection, the writhing reflex was counted for 10 min. The writhing reflex was defined as a lengthwise stretch of the trunk with concave arching of the back. The gas mixture was continuously delivered into the chamber during the writhing test. Evaluation of the antinociceptive effect against somatic pain in WT and KOP-KO mice was performed using a hot-plate test (n¼30, respectively). 14 The results from two KOP-KO mice
were not included in the analysis, because pretreatment drug solution was partially leaked at s.c. administration. After pretreatment, mice inhaled the gas for 30 min, and were then put on a hot plate (Muromachi Kikai, Tokyo, Japan) at 558C. Latency was defined as the time to lick the hind legs or jump with a cut-off time of 30 s to avoid tissue damage. The initial sevoflurane concentration was 0.8% atm. After equilibration for 20 min, the chamber was gently rotated to place the mouse on its back and the righting response was observed for 10 s. The sevoflurane concentration was increased in 0.3% increments and the response was re-examined after equilibration for 20 min. EC 50 -LORR was defined as the midpoint between the highest concentration at which the mouse showed a righting response and the lowest concentration at which the mouse did not respond.
Measurement of sevoflurane EC 50 -LORR
c-Fos immunohistochemical study
Immunohistochemical study was performed in WTand KOP-KO mice (n¼10, respectively), by the method described by Toda and others. 16 After 90 min exposure to 30% O 2 +70% N 2 (n¼5) or 30% O 2 +70% N 2 O (n¼5), mice were killed with sodium pentobarbital (100 mg kg 21 , i.p.) injection, followed by transcardial perfusion with 20 ml of 0.1 M phosphatebuffered saline (pH 7.2) (PBS) and subsequently 20 ml of the fixative solution (4% paraformaldehyde in 0.1 M PBS). The lumbar spinal cord (approximately L4/L5 level) was obtained by rapid PBS injection into the spinal canal and post-fixed in the fixative solution for 6 h. The samples were incubated in 20% sucrose in 0.1 M PBS for 24 -36 h, embedded in optimal cutting temperature compound (OTC) (Tissue-Tek; Sakura Finetechnical, Tokyo, Japan), and frozen at 2808C. Sections (5 mm thick) were prepared by the use of a cryostat at 2228C and mounted on slide glasses. After rinsing with PBS (5 min, six times), the sections were treated with absolute methanol containing 0.3% H 2 O 2 for 30 min at room temperature to quench endogenous peroxidase activity, and then were treated with 1.3% goat serum (Vector Laboratories, Burlingame, CA, USA) for 30 min to block non-specific binding of the antibody. Thereafter, the slides were incubated overnight at 48C with primary rabbit anti-c-Fos antibody (1:200, sc-52, Santa Cruz Biotechnology, Santa Cruz, CA, USA), incubated with biotinylated anti-rabbit IgG antibody (Vector Laboratories) for 40 min at room temperature, and then incubated with avidin -biotin -peroxidase complex (Vector Laboratories) for 50 min at room temperature. Colour development was performed with 0.03% 3,3
′ -diaminobenzidine tetrahydrochloride (Dojindo Laboratories, Tokyo, Japan). Slides were counterstained using 0.1% Mayer's haematoxylin.
The sections were then dehydrated using an alcohol gradient, cleared using xylene, and coverslipped. Brown nuclear staining was regarded as a c-Fos-immunopositive cell, and the number of these cells in each section from the lumbar spinal cord was estimated using an Olympus DP73 microscope. The distribution of c-Fos-immunopositive cells was examined in four regions: the superficial dorsal horn (laminae I -II), nucleus proprius (laminae III-IV), neck of the dorsal horn (laminae V -VI), and ventral gray (laminae VII -X), 17 in three randomly selected sections in each mouse. The results are expressed as the mean number of c-Fos-immunopositive cells per section.
Statistical analysis
The sample size in each experiment was predetermined using power analysis by the use of G Power software based on previous reports to provide the appropriate power (12b¼0.8). MAC measurement was powered to detect a 20% change in MAC by opioid receptor KO 8 with a variance of 0.3% for sevoflurane and 0.1% for isoflurane. 5 For assessment of the N 2 O effect on sevoflurane MAC, measurement of antinociceptive effects, and c-Fos immnohistochemical study, power analysis was performed by assuming differences and variances similar to those in our previous study. 5 For the effect of N 2 O on sevoflurane EC 50 -LORR, sample size calculation was performed by assuming that N 2 O induces 50% reduction in EC 50 -LORR of volatile anaesthetics. 7 A larger number of mice were enrolled in the study to allow for possible incomplete data collection. Data were analysed by unpaired t-test for pairwise comparisons or by one-way analysis of variance (ANOVA) followed by the Bonferroni correction as a post hoc test using Prism 5 software (GraphPad Software, Inc., San Diego, CA, USA). The results are expressed as mean (SD). In all analyses, a P-value of ,0.05 was considered significant.
Results
MAC of volatile anaesthetics and N 2 O
First, we tested whether KOP is involved in the action of N 2 O and volatile anaesthetics that is estimated by MAC, because MAC has been frequently used to compare anaesthetic potency of different inhaled anaesthetics. No significant difference in the MAC for isoflurane or sevoflurane was found between WT and KOP-KO mice ( Table 1 ), suggesting that KOP does not significantly contribute to the pharmacological effect of isoflurane and sevoflurane estimated by MAC. Next, we indirectly examined whether N 2 O MAC is affected by KOP by measuring the sevoflurane MAC in the absence and presence of N 2 O in WT and KOP-KO mice, because there was no significant difference in sevoflurane MAC between these mice (Fig. 1) . The (Fig. 1 ). Significant reduction in the sevoflurane MAC was induced by U-50488 in WT mice (P,0.01), but not in KOP-KO mice.
Antinociceptive action of N 2 O Figure 2 depicts the writhing responses of mice to i.p. injection of acetic acid. The writhing count was significantly decreased by N 2 O and U-50488 in WT mice (P,0.05), but neither N 2 O nor U-50488 decreased the writhing count in KOP-KO mice. Figure 3 demonstrates the result of the hot-plate test comparing the antinociceptive action of N 2 O against somatic noxious stimulus. In WT mice, the latency was prolonged by N 2 O and U-50488 compared with control (P,0.05). In contrast, in KOP-KO mice, no significant prolongation of the latency was produced by N 2 O or U-50488. These results show that the antinociceptive action of N 2 O and U-50488 are almost completely eliminated in KOP-KO mice.
N 2 O-induced c-Fos expression in the lumbar spinal cord
Activation of g-aminobutyric acid (GABA)-producing interneurons by N 2 O through the action of the spinal descending inhibitory system was evaluated by immunohistochemical assessment of c-Fos protein expression in the lumbar spinal cord of WTand KOP-KO mice (Fig. 4) . Under control conditions, there 
Discussion
The results of this study using KOP-KO mice provide insights into the mechanisms of the pharmacological actions of N 2 O and volatile anaesthetics. KOP gene deletion almost completely abolished the antinociceptive effect and sevoflurane MAC-reducing effect of N 2 O, but did not significantly affect the hypnotic action of N 2 O. Furthermore, KOP gene deletion did not significantly affect MAC and hypnotic action of the volatile anaesthetics. The mechanisms of general anaesthesia by volatile anaesthetics have been explored, and some researchers have reported that MOP is involved in its action. 8 However, our previous study showed that the MAC values, which reflect the potency of inhaled anaesthetics for immobilizing action to noxious stimulation, of sevoflurane, isoflurane, and halothane in MOP-deleted mice were not significantly different from those in WT mice. 5 This suggests that MOP does not contribute to the immobilizing action to noxious stimulation of volatile anaesthetics. However, contribution of KOP to the pharmacological action of volatile anaesthetics has not been previously examined. The current study showed that MAC of volatile anaesthetics, isoflurane and sevoflurane, was not influenced by genetic deletion of KOP, which suggests that the immobilizing action in response to noxious stimulation of these anaesthetics is not mediated by KOP. Collectively, these findings suggest that opioid receptors do not play essential roles in the action of volatile anaesthetics, and thus we decided to compare N 2 O-induced decrease in MAC of volatile anaesthetics between WT and KOP-KO mice in order to indirectly assess whether the MAC of N 2 O is affected by KOP activity. Because essentially identical results were expected for sevoflurane and isoflurane, we used sevoflurane as a representative of volatile anaesthetics. The MAC of N 2 O is higher than 100%, which prevents direct measurement of the MAC at atmospheric pressure. However, the MAC of N 2 O can be estimated indirectly by measuring MAC for volatile anaesthetics with and without N 2 O, because MAC values are additive. 18 In the current study, co-administration of 70% N 2 O decreased the sevoflurane MAC by about 40% in WT mice, which indicates that 70% N 2 O corresponds to 40% of the MAC, giving a MAC for N 2 O of nearly 175%. This value is similar to the results of direct determination of N 2 O MAC values. 19 Injection of a KOP-selective agonist, U-50488, also reduced the sevoflurane MAC in WT mice, indicating that KOPmediated analgesia can reduce MAC and that the immobilizing action estimated by MAC includes the antinociceptive component. In contrast, in KOP-KO mice, N 2 O did not significantly influence the sevoflurane MAC, suggesting that the immobilizing 21 We have shown that inhalation of 70% N 2 O significantly increases the number of c-Fos-immunopositive cells in laminae III-IV in WT and MOP-KO mice, which reflects activation of GABAergic interneurons by the noradrenergic descending inhibitory pathway in the mouse spinal cord. 5 The current study showed that the number of c-Fos-immunopositive cells was not increased in laminae III-IV of the lumbar spinal cord by inhalation of 70% N 2 O in KOP-KO mice in contrast to WT mice. This finding agrees with our result showing that the antinociceptive action of N 2 O was almost completely abolished by genetic deletion of KOP, and suggests that N 2 O produces antinociceptive action through KOP-mediated activation of the descending inhibitory pathway. General anaesthetics produce various pharmacological effects, including antinociception, muscle relaxation, and hypnosis. We next aimed to investigate whether the hypnotic and antinociceptive components of N 2 O action are mediated by different mechanisms. Because the hypnotic action of N 2 O is relatively small and it is difficult to estimate EC 50 -LORR of N 2 O directly, we assessed the hypnotic action of N 2 O by measuring the N 2 O-induced reduction of EC 50 -LORR of sevoflurane. 7 There was no significant difference in the sevoflurane EC 50 -LORR between WT and KOP-KO mice, and this value was reduced by addition of 70% N 2 O to essentially identical extent in both genotypes, suggesting that the hypnotic effect of N 2 O occurs mainly through a mechanism that does not involve KOP. Consistent with this, KOP activation by a KOP-selective agonist, U-50488, did not affect sevoflurane EC 50 -LORR.
There have been many reports on the mechanisms of the antinociceptive action of N 2 O. We have shown the involvement of nociceptin receptors in this action 22 23 and inhibition of glutamatergic transmission by N 2 O in the spinal cord was also reported. 24 Sawamura and colleagues 25 found that the antinociceptive action of N 2 O in a2B-adrenergic receptor KO mice is significantly lower than that in WT mice. Corticotropinreleasing factor-producing neurones and noradrenergic neurones present in the locus coeruleus have also been linked to the N 2 O action. 26 Nitric oxide produced at the supraspinal level 27 and spinal level 28 may also participate in the antinociceptive action of N 2 O in mouse and rat. Further studies are obligatory to solve how these various mechanisms and the mechanism mediated by KOP, which was demonstrated to play a central role in the antinociceptive action of N 2 O in the current study, are related. There are several limitations in this study. First, we have no direct evidence that KOP is activated by administration of N 2 O, although KOP was shown to be indispensable for the antinociceptive action of N 2 O. Demonstration of activation of KOP-expressing neurons or increased production or secretion of dynorphin, an endogenous peptide selectively activating KOP, by N 2 O is required to show N 2 O-induced KOP activation. Secondly, a compensatory physiological change activated by deletion of KOP might affect the mechanism of action of N 2 O. We cannot completely rule out this possibility, but it is unlikely that MOP or DOP, expression of which might be increased by KOP deletion, affects N 2 O action, because we have previously shown that MOP and DOP do not significantly contribute to N 2 O action. 5 6 Thirdly, although the sevoflurane EC 50 -LORR in WT and KOP-KO mice did not significantly differ, it remains possible that the slope of the dose -response curve for sevoflurane-induced LORR and the effect N 2 O on the slope is different between these mice. Thus, the possibility that KOP is involved in the hypnotic action of N 2 O is not completely excluded.
In conclusion, we demonstrated that N 2 O exerts its antinociceptive action and reduces MAC of volatile anaesthetics in mice through activation of KOP and the descending inhibitory pathway in the spinal cord, while its hypnotic potency is not dependent on KOP activation.
